6
Participants
Start Date
November 30, 2016
Primary Completion Date
December 31, 2017
Study Completion Date
September 30, 2018
C-14 labeled Rucaparib
Each dosage unit consists of a hard gelatin capsule filled with cold rucaparib camsylate and \[14C\]-rucaparib camsylate salt. Each capsule contains approximately 150 mg rucaparib (free base weight) and approximately 35 µCi of \[14C\]-rucaparib. Each patient will ingest four capsules in the fasted state for a total dose of 600 mg rucaparib (free base weight) with approximately 140 µCi of \[14C\]-rucaparib
Rucaparib
200 \& 300 mg tablet
PRA Magyarország Kft., Budapest
pharmaand GmbH
INDUSTRY